Out of Covaxin, Delhi govt urges Serum Institute to 'come to rescue' & provide Covishield

Amid the concerns over vaccine shortage in the national capital, the Delhi government wrote to the Serum Institute of India (SII) asking it to "come to its rescue".

After Bharat Biotech said it cannot supply more doses of Covaxin to Delhi, the city government wrote to the Serum Institute of India (SII) asking it to "come to its rescue", saying it has limited stock of Covishield for 18 to 44 years which will finish in one week. To this, the SII said they are doing their best to meet countrywide vaccine requirements, official sources said.